Yemen Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Yemen Health Report.

Press releases published on July 15, 2026

36 minutes ago

Cellectar Biosciences Announces Publication of Phase 1 Study of Iopofosine I 131 in Peer-Reviewed Journal Cancers

Indeterminate GlobeNewswire

36 minutes ago

BriaCell Arranges Scalable Manufacturing with FUJIFILM Biotechnologies for Bria-IMT™

Indeterminate GlobeNewswire

36 minutes ago

Repligen to Report Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

36 minutes ago

Senti Biosciences Holdings, Inc. Announces a Strategic Transaction to Unlock Value for its Gene-Circuit-Enabled Pipeline, Including SENTI-202, and to Sharpen its Focus on Next-Generation Controllable Genetic Medicines Powered by its Regulator Dial™…

Indeterminate GlobeNewswire

36 minutes ago

Acumen Pharmaceuticals Highlights Enhanced Brain Delivery™ (EBD™) Program Data and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 2026

Indeterminate GlobeNewswire

an hour ago

Axogen, Inc. to Report Second Quarter 2026 Financial Results on July 29, 2026

Indeterminate GlobeNewswire

an hour ago

BioCryst Appoints David W. Jenkins as Chief Scientific Officer

Indeterminate GlobeNewswire

an hour ago

INmune Bio’s XPro1595 Prevents Brain-Injury-Induced Alzheimer's Pathology, Memory Loss, and Pain in New Peer-Reviewed Preclinical Study

Indeterminate GlobeNewswire

an hour ago

Axsome Therapeutics Announces FDA Acceptance of New Drug Application for AXS-12 for the Treatment of Cataplexy in Narcolepsy

Indeterminate GlobeNewswire

an hour ago

Tempest Unveils Next-Generation In Vivo CAR-T Pipeline, with First Clinical Study Planned for the Fourth Quarter of 2026

Indeterminate GlobeNewswire

an hour ago

BPGbio Reports Encouraging Preliminary Data from Ongoing Phase 2 Study of BPM31510 in Newly Diagnosed Glioblastoma

Indeterminate GlobeNewswire

2 hours ago

Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2026

Indeterminate GlobeNewswire

2 hours ago

Fractyl Health Reports Positive Randomized Data from REMAIN-1 Midpoint Cohort Demonstrating Durable Weight Maintenance One Year After GLP-1 Discontinuation

Indeterminate GlobeNewswire

3 hours ago

Nxera Pharma Webinar for Financial Results Presentation - 2Q2026

Indeterminate GlobeNewswire

5 hours ago

Epoch Biotech Highlights New Preclinical Data for APOE Christchurch-Mimetic Antibody at AAIC 2026 Demonstrating Favorable PK/PD and Differentiated Biomarker Approach

Indeterminate GlobeNewswire

5 hours ago

WONDERLAB Spotlights Gut Health and Innate Immunity, Featuring Its Proprietary Strain GOLDGUT-M520

Indeterminate GlobeNewswire

6 hours ago

Boehringer Ingelheim reports first-half 2026 sales growth, driven by JARDIANCE® and new product launches in the U.S.

Indeterminate GlobeNewswire

7 hours ago

Molecular Partners Showcases Bispecific Radio-DARPins at Gordon Research Conference

Indeterminate GlobeNewswire

8 hours ago

Closing of Previously Announced Restructuring Transaction in Connection with CCAA Proceedings

Indeterminate GlobeNewswire

10 hours ago

Crescent Biopharma Announces Pricing of Public Offering of Ordinary Shares and Pre-Funded Warrants

Indeterminate GlobeNewswire